To further study the association between ASRGL1 loss in ALS individuals and the presence of cytoplasmic TDP-43, we explored whether TDP-43 could be a substrate of ASRGL1 and if the loss of this enzyme could have a role in the formation of TDP-43 proteinopathy. This evidence concerns the gene ASRGL1 and proteostasis deficiencies.